Gastroenterology & GI Surgery

Welcome to the Mayo Clinic Gastroenterology & GI Surgery Page! With one of the largest group of digestive disease specialists in the world, Mayo Clinic has been recognized as the nation's best Gastroenterology & GI Surgery hospital by U.S. News & World Report. Follow the page to learn about clinical trials and up-to-date research, and find resources for all your gastroenterology needs. Our goal is to connect you to others, and become informed decision makers; so post a comment, share your story, own your health.

Sep 4, 2014

Anti-TNF Agents for Crohn’s Disease

By Kanaaz Pereira, Connect Moderator, @kanaazpereira

Sunanda Kane, M.D., discusses a recently published study in Alimentary Pharmacology & Therapeutics about the superiority of anti-TNF agents for Crohn’s disease.

Patients are interested in knowing if one anti-TNF agent is better than the others. Researchers at the University of Michigan conducted a study using statistical methods from previous studies. The results showed there was no difference between using Remicade, Humira, or Cimzia to induce remission of Crohn's disease. Whether it's by IV or injection, all three methods were effective at treating Crohn's disease. This is a novel study that takes data already available and compares the outcomes statistically. The results give an idea of whether there is a trend indicating which medicine is better for treatment. In this study, the results show that all three medications appear to be equivalent for treating Crohn's disease.

Read the full study online here.

For more information about IBD, visit

Dr. Kane is a gastroenterologist at Mayo Clinic.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Gastroenterology & GI Surgery page.

Please login or register to send an invite.